Analyst Price Targets — CC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 10, 2026 12:26 pm | Arun Viswanathan | RBC Capital | $26.00 | $22.86 | TheFly | Chemours price target raised to $26 from $21 at RBC Capital |
| April 9, 2026 12:14 pm | — | UBS | $29.00 | $21.84 | TheFly | Chemours price target raised to $29 from $23 at UBS |
| April 9, 2026 10:10 am | — | Truist Financial | $27.00 | $21.84 | TheFly | Chemours price target raised to $27 from $21 at Truist |
| February 23, 2026 4:57 pm | Laurence Alexander | Jefferies | $17.00 | $18.16 | StreetInsider | Chemours (CC) PT Raised to $17 at Jefferies |
| February 23, 2026 2:00 pm | — | UBS | $23.00 | $17.64 | TheFly | Chemours price target raised to $23 from $18 at UBS |
| February 23, 2026 1:47 pm | — | BMO Capital | $19.00 | $17.69 | TheFly | Chemours price target lowered to $19 from $20 at BMO Capital |
| February 23, 2026 12:40 pm | — | Mizuho Securities | $17.00 | $17.04 | TheFly | Chemours price target raised to $17 from $14 at Mizuho |
| February 23, 2026 12:28 pm | Vincent Andrews | Morgan Stanley | $17.00 | $17.04 | TheFly | Chemours price target raised to $17 from $15 at Morgan Stanley |
| January 21, 2026 11:17 am | — | Truist Financial | $21.00 | $15.26 | TheFly | Chemours price target raised to $21 from $18 at Truist |
| January 19, 2026 12:03 pm | John McNulty | BMO Capital | $20.00 | $15.61 | TheFly | Chemours price target raised to $20 from $18 at BMO Capital |
Latest News for CC
On April 10, 2026, The Chemours Co (CC) shares experienced a notable increase of 4.0% today, bringing the current price to $22.71. This price movement is signif
SG Americas Securities LLC grew its position in The Chemours Company (NYSE: CC) by 478.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 236,236 shares of the specialty chemicals company's stock after purchasing an additional 195,393 shares during the quarter.
The article analyzes the Canton Network and its CIP-0105 update, which incentivizes Super Validators to lock rewards, aligning interests with long-term network success. CIP-0105 could result in 20–32% of Canton Coin supply being locked over the long run, reducing circulating supply and disincentivizing opportunistic selling. Major financial institutions like Nasdaq, DTCC, and others serve as Super Validators,…
The Chemours Company (NYSE: CC - Get Free Report) saw some unusual options trading activity on Friday. Stock investors purchased 10,642 call options on the company. This is an increase of 182% compared to the typical volume of 3,771 call options. Chemours Stock Performance Shares of CC stock opened at $17.60 on Friday. Chemours has a
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (the "Notes") that was exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.